BPG is committed to discovery and dissemination of knowledge
Featured Articles
4/19/2016 4:19:00 PM | Browse: 577 | Download: 2147
 |
Received |
|
2016-01-21 14:15 |
|
Peer-Review Started |
|
2016-01-21 17:49 |
 |
First Decision by Editorial Office Director |
|
|
|
Return for Revision |
|
2016-02-19 13:46 |
|
Revised |
|
2016-03-01 15:31 |
|
Publication Fee Transferred |
|
|
|
Second Decision by Editor |
|
2016-03-04 18:04 |
|
Second Decision by Editor-in-Chief |
|
|
|
Final Decision by Editorial Office Director |
|
2016-03-14 10:26 |
|
Articles in Press |
|
2016-03-14 10:26 |
|
Edit the Manuscript by Language Editor |
|
2016-03-18 08:49 |
|
Typeset the Manuscript |
|
2016-04-07 09:08 |
|
Publish the Manuscript Online |
|
2016-04-19 09:42 |
| ISSN |
1007-9327 (print) and 2219-2840 (online) |
| Open Access |
This article is an open-access article which was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/
|
| Copyright |
© The Author(s) 2016. Published by Baishideng Publishing Group Inc. All rights reserved.
|
| Article Reprints |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
|
| Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
| Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
| Website |
http://www.wjgnet.com |
| Category |
Gastroenterology & Hepatology |
| Manuscript Type |
Prospective Study |
| Article Title |
Predictive effects of bilirubin on response of colorectal cancer to irinotecan-based chemotherapy
|
| Manuscript Source |
Unsolicited Manuscript |
| All Author List |
Qian-Qian Yu, Hong Qiu, Ming-Sheng Zhang, Guang-Yuan Hu, Bo Liu, Liu Huang, Xin Liao, Qian-Xia Li, Zhi-Huan Li and Xiang-Lin Yuan |
| Funding Agency and Grant Number |
| Funding Agency |
Grant Number |
| National Natural Science Foundation of China |
81372664 |
|
| Corresponding Author |
Xiang-lin Yuan, PhD, MD, Professor of Medicine, Department of Oncology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, 1095 Jiefang Avenue, Wuhan 430030, Hubei Province, China. yxl@medmail.com.cn
|
| Key Words |
Bilirubin; Irinotecan; Metastatic colorectal cancer; Response; UGT1A1*28 |
| Core Tip |
Serum bilirubin was reported to be associated with irinotecan-induced toxicity. The current study evaluated whether baseline bilirubin levels could predict treatment response of metastatic colorectal cancer patients given irinotecan-based chemotherapy in a Chinese population and found that a lower bilirubin level was an independent predictor of irinotecan treatment response.
|
| Publish Date |
2016-04-19 09:42 |
| Citation |
Yu QQ, Qiu H, Zhang MS, Hu GY, Liu B, Huang L, Liao X, Li QX, Li ZH, Yuan XL. Predictive effects of bilirubin on response of colorectal cancer to irinotecan-based chemotherapy. World J Gastroenterol 2016; 22(16): 4250-4258
|
| URL |
http://www.wjgnet.com/1007-9327/full/v22/i16/4250.htm |
| DOI |
http://dx.doi.org/10.3748/wjg.v22.i16.4250 |
Copyright © 1993-2026 Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA. All rights reserved, including rights relating to text and data mining, AI training, and similar technologies. For open-access content, the applicable copyright and licensing terms govern.
